Ipilimumab/Nivolumab for Immune Checkpoint Inhibitor-induced Encephalitis

Janssen, S; Lindhof, HH

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023; 21 (): 166